Boehringer Chief: Health Reform Plans Imbalanced

The head of Boehringer Ingelheim criticized Germany’s proposed health reform plans. He stated the plans are unbalanced and lack necessary adjustments. This raises concerns about the future of healthcare in Germany and potential impacts on the pharmaceutical industry.

Summarized from the sources above. Read the originals for the full story.